Meeder Advisory Services Inc. Takes Position in CVS Health Corporation $CVS

Key Points

• Meeder Advisory Services acquired 24,886 CVS Health shares worth approximately $2.57 million during the second quarter, while institutional investors collectively own 80.66% of the company.
• CVS reported strong quarterly results, with EPS of $2.58 versus the $1.87 consensus estimate and revenue of $106.1 billion. The company also raised its 2026 adjusted operating-income outlook, supporting its turnaround narrative.
• Analysts remain broadly positive, with 22 Buy ratings and two Holds producing a “Moderate Buy” consensus and an average price target of $106.75.

Meeder Advisory Services Inc. bought a new stake in shares of CVS Health Corporation (NYSE:CVS - Free Report) during the 2nd quarter, according to its most recent filing with the SEC. The firm bought 24,886 shares of the pharmacy operator's stock, valued at approximately $2,574,000.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the stock. Beaird Harris Wealth Management LLC lifted its position in shares of CVS Health by 201.0% during the second quarter. Beaird Harris Wealth Management LLC now owns 292 shares of the pharmacy operator's stock worth $30,000 after purchasing an additional 195 shares in the last quarter. J.Safra Asset Management Corp acquired a new position in CVS Health in the 2nd quarter worth $30,000. Dunhill Financial LLC purchased a new position in CVS Health in the 2nd quarter valued at about $32,000. Swiss RE Ltd. acquired a new stake in shares of CVS Health during the fourth quarter valued at about $26,000. Finally, Sankala Group LLC purchased a new stake in shares of CVS Health during the fourth quarter worth about $28,000. Hedge funds and other institutional investors own 80.66% of the company's stock.

Key Headlines Impacting CVS Health

Here are the key news stories impacting CVS Health this week:

• Positive Sentiment: CVS reported strong second-quarter results, with earnings per share rising more than 40% year over year as profitability in its Health Care Benefits segment improved. The company also raised its 2026 adjusted operating income outlook, reinforcing the recovery story. CVS Q2 EPS Gains From Improved Health Care Benefits Profitability
• Positive Sentiment: CVS appointed Teresa Heitsenrether, JPMorgan’s data and analytics chief, to its board. Her technology, analytics and operating experience could support CVS’s artificial-intelligence and data initiatives, potentially improving efficiency and decision-making across its businesses. CVS adds JPMorgan data executive to board amid AI push
• Positive Sentiment: Brokerages assigned CVS an average “Moderate Buy” rating, reflecting improved earnings momentum and optimism about Aetna’s performance. CVS Health Given Average Rating of Moderate Buy

Wall Street Analyst Weigh In

CVS has been the subject of a number of analyst reports. Sanford C. Bernstein increased their price target on CVS Health from $94.00 to $106.00 and gave the company an "outperform" rating in a report on Tuesday, May 12th. Wells Fargo & Company upped their target price on CVS Health from $103.00 to $123.00 and gave the company an "overweight" rating in a research report on Monday, July 13th. Mizuho increased their target price on CVS Health from $110.00 to $115.00 and gave the company an "outperform" rating in a research note on Monday, June 8th. Wall Street Zen upgraded shares of CVS Health from a "buy" rating to a "strong-buy" rating in a research note on Saturday, August 8th. Finally, Barclays increased their price objective on shares of CVS Health from $106.00 to $108.00 and gave the company an "overweight" rating in a research note on Thursday, August 6th. Twenty-two equities research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company's stock. According to MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average price target of $106.75.

CVS Health Stock Performance

Shares of CVS opened at $94.87 on Wednesday. The stock has a market capitalization of $121.33 billion, a PE ratio of 25.10, a price-to-earnings-growth ratio of 0.93 and a beta of 0.61. The business's fifty day moving average price is $102.41 and its 200 day moving average price is $88.56. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.87 and a quick ratio of 0.66. CVS Health Corporation has a 12-month low of $69.51 and a 12-month high of $110.68.

CVS Health (NYSE:CVS - Get Free Report) last posted its quarterly earnings results on Wednesday, August 5th. The pharmacy operator reported $2.58 EPS for the quarter, beating the consensus estimate of $1.87 by $0.71. The business had revenue of $106.10 billion during the quarter, compared to analyst estimates of $100.03 billion. CVS Health had a net margin of 1.18% and a return on equity of 13.12%. The company's quarterly revenue was up 7.3% on a year-over-year basis. During the same period in the previous year, the business posted $1.81 EPS. CVS Health has set its FY 2026 guidance at 7.900-8.100 EPS. Equities research analysts forecast that CVS Health Corporation will post 8.02 EPS for the current year.

CVS Health Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Monday, August 3rd. Stockholders of record on Thursday, July 23rd were given a dividend of $0.665 per share. This represents a $2.66 dividend on an annualized basis and a dividend yield of 2.8%. The ex-dividend date was Thursday, July 23rd. CVS Health's dividend payout ratio is presently 70.37%.

Insider Activity

In related news, Director Larry Robbins sold 370,462 shares of the business's stock in a transaction that occurred on Thursday, May 21st. The stock was sold at an average price of $93.45, for a total transaction of $34,619,673.90. Following the completion of the transaction, the director owned 4,824,799 shares in the company, valued at $450,877,466.55. The trade was a 7.13% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Company insiders own 0.85% of the company's stock.

CVS Health Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source